- Supported exchanges /
- SHE /
- 301281.SHE
Shandong Keyuan Pharmaceutical Co. Ltd. A (301281 SHE) stock market data APIs
Shandong Keyuan Pharmaceutical Co., Ltd. involves in research and development, manufacturing, and marketing of active pharmaceutical ingredients. It offers gliclazide, for the treatment of NIDDM; metformin hydrochloride used as an adjunct to diet and exercise in adult patients with NIDDM; isosorbide mononitrate for prevention of angina pectoris and treatment of acute and chronic angina pectoris, hypertension, and myocardial infarction; isosorbide dinitrate to prevent angina pectoris due to coronary artery disease; mecobalamin for peripheral neuropathies; lansoprazole to treat acid-reflux disorders, peptic ulcer disease, h. pylori eradication, and prevention of gastrointestinal bleeds; ropivacaine hydrochloride for obstetric and regional anesthesia; fluoxetine hydrochloride, an anti-depression drug; clemastine fumarate, an anti-allergic agent; isoprenaline hydrochloride to treat mild or transient episodes of heart block; esmolol hydrochloride for the rapid control of ventricular rate; xanthinol nicotinate to treat of brain function barrier, cerebral embolism and cerebral thrombosis; amlexanox for treatment of aphthous ulcers; nisolsipine for hypertension; clarithromycin lactobionate; trepibutone; propafenone hydrochloride; diclofenac potassium to treat osteoarthritis and rheumatoid arthritis; chlorzoxazone for relief of discomfort associated with acute painful musculoskeletal conditions; esomeprazole sodium treats related gastric ulcer disease and zollinger-ehrlich syndrome; palonosetron hydrochloride, a chemotherapy adjuvant medication; edaravone, a cerebral protective agent; vildagliptin to treat diabetes; etamsylate, a hemostatic medication; pranoprofen that is a non-steroidal anti-inflammatory analgesic and antipyretic drugs; parecoxib sodium; and lurasidone hydrochloride, a medication for schizophrenia. The company was incorporated in 2004 and is headquartered in Jinan, China.
Shandong Keyuan Pharmaceutical Co. Ltd. A Financial Data Overview
| 35.58 | |
| 35.2 | |
| - | |
| 36.14 | |
| 34.68 | |
| 18.52-58.66 | |
| 3 813 M | |
| 76.5435 | |
| 108 M | |
| 438 M | |
| 0.0332 | |
| 0.0085 | |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Shandong Keyuan Pharmaceutical Co. Ltd. A Fundamental Data is available in our Financial Data APIs
- Net Revenue 438 M
- EBITDA 91 649 K
- Earnings Per Share 0.46
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Shandong Keyuan Pharmaceutical Co. Ltd. A Earnings via APIs
- Latest Release 2024-09-30
- EPS/Forecast NaN
Get Shandong Keyuan Pharmaceutical Co. Ltd. A End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
